Medpace (NSDQ:MEDP) today priced an upcoming secondary offering which could bring in up to approximately $247.5 million.
In the offering, the Cincinnati-based company said that investment funds affiliated with Cinven Capital Management will offer approximately 4.5 million shares of its stock at a price of $55 per share.